Johnson & Johnson (JNJ) Drug Pipeline
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Intralipid, Ici35,868, Ici35,868 + Ees0000645/A | Sedation To Be Moderate For A Diagnostic Gastrointestinal Endoscopy And Gastrointestinal Endoscopic Polypectomy | Phase III | Completed | Phase III Study of ICI35,868 (Diprivan) With and Without EES0000645/A (SDS) on Gastrointestinal Endoscopy | Oct 10, 2013 | ― |
| Golimumab | Spondylitis, Ankylosing | Phase III | Completed | Effect of Golimumab in Participants With Active Axial Spondyloarthritis (P07642, MK-8259-006) | Oct 13, 2011 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Intralipid, Ici35,868, Ici35,868 + Ees0000645/A | Phase III | Sedation To Be Moderate For A Diagnostic Gastrointestinal Endoscopy And Gastrointestinal Endoscopic Polypectomy | Completed | Phase III Study of ICI35,868 (Diprivan) With and Without EES0000645/A (SDS) on Gastrointestinal Endoscopy | Oct 10, 2013 | ― |
| Golimumab | Phase III | Spondylitis, Ankylosing | Completed | Effect of Golimumab in Participants With Active Axial Spondyloarthritis (P07642, MK-8259-006) | Oct 13, 2011 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Johnson & Johnson (DE:JNJ) have in its pipeline
Johnson & Johnson DE:JNJ is currently developing the following drugs: Intralipid, Ici35,868, Ici35,868 + Ees0000645/A, Golimumab. These drug candidates are in various stages of clinical development as the company works toward FDA approval.
